Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV429
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,648
Award facts
- Contract value 100% obligated
- $87,648.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $87,648.01 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors. This non-competitive, firm fixed-price delivery order was executed on January 12, 2026, with an ultimate completion date of January 13, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under a larger Indefinite Delivery Contract vehicle established between the DLA Troop Support Medical and the company's parent entity, Cencora, Inc., valued at up to $999.999 billion through December 2031.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military healthcare systems, supplying a comprehensive range of medications, vaccines, and medical supplies through its relationship with the Defense Logistics Agency. Dupixent is a specialty biologic medication used for treating conditions such as moderate-to-severe atopic dermatitis and asthma, indicating this delivery supports the medical supply chain for military treatment facilities and veterans' healthcare programs. The parent company, Cencora, Inc., operates as one of the nation's largest pharmaceutical distributors and competes on a full and open basis for federal contracts, demonstrating substantial capacity to meet government healthcare procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FV429?
SPE2DR26FV429 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV429 worth?
The government has obligated $87,648 on SPE2DR26FV429.
Is contract SPE2DR26FV429 an order under another contract?
Yes. SPE2DR26FV429 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV429 competed?
The extent of competition for SPE2DR26FV429 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award